News

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.
A stem cell-based treatment may have cured 10 out of 12 patients with the most severe form of type 1 diabetes — during a ...
Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.
Researchers at Vertex Pharmaceuticals in Boston say a single infusion of stem cell-based treatment could be a permanent ...
This was the stock's second consecutive day of gains.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best biotech stocks to invest in now. On June 20, Vertex ...
TUESDAY, June 24, 2025 (HealthDay News) — A single infusion of a new stem cell-based treatment may have helped 10 out of 12 ...
A study may have found a cure for type 1 diabetes. Here, experts explain how the treatment, zimislecel, works and what it ...
Vertex Pharmaceuticals locked arms with Ono Pharmaceutical in an exclusive deal to advance povetacicept, targeting B ...
CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...
"This edition of the Healthcare Enforcement column discusses two judicial decisions from recent months relating to the ...